[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100376726":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":11,"centralContacts":23,"locations":32,"responsibleParty":53,"collaborators":11,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":11,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":11,"enrollmentInfo":64,"targetDuration":11,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":11,"overallStatus":34,"whyStopped":11,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Institut Paoli-Calmettes","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"non-metastatic colon cancer","EXPERIMENTAL",null,[13],"Biological: analysis of BTN and BTNL status",{"label":15,"type":10,"description":11,"interventionNames":16},"metastatic colon cancer",[13],[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":11},"BIOLOGICAL","analysis of BTN and BTNL status","analysis of BTN and BTNL expression in colon cancer and hepatic metastasis",[15,9],[24,29],{"name":25,"role":26,"phone":27,"phoneExt":11,"email":28},"Jihane PAKRADOUNI, PharmD,PhD","CONTACT","04 91 22 37 78","drci.up@ipc.unicancer.fr",{"name":30,"role":26,"phone":31,"phoneExt":11,"email":28},"Laurie-Anne GOUTY, PhD","33491223778",[33],{"facility":5,"status":34,"city":35,"state":11,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","Marseille","13273","France","FR",{"type":40,"coordinates":41},"Point",[42,43],5.38107,43.29695,{"lat":43,"lon":42},[46,48,50],{"name":47,"role":26,"phone":31,"phoneExt":11,"email":28},"Jihane PAKRADOUNI, PharmD, PhD",{"name":30,"role":26,"phone":49,"phoneExt":11,"email":28},"0491223778",{"name":51,"role":52,"phone":11,"phoneExt":11,"email":11},"Hélène MEILLAT","PRINCIPAL_INVESTIGATOR",{"type":54,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100376726","butyrophilins-role-in-colon-cancer-100376726",false,"NCT04185272","Butyrophilins Role in Colon Cancer","Role of Butyrophilins in Colon Cancers Aggressiveness Evaluation","Inclusion Criteria:\n\n* Patient is older than 18 years old,\n* Signed participation consent,\n* Non-metastatic colon cancer immediately resectable or metastatic and liver synchronous for which it was decided a combined colic and liver surgery (metastatic patient at the outset) in multidisciplinary consultation meeting.\n* Performance Status (PS) 0 or 1\n* affiliated to the social security or beneficiary\n\nExclusion Criteria:\n\n* Rectal cancer, colon cancer recurrence\n* Emergency of colon cancer Surgery\n* History of inflammatory disease of the digestive tract (Crohn's disease or ulcerative colitis)\n* Patient who received neoadjuvant therapy other than chemotherapy\n* Patient treated with immune-suppressors or long-course corticosteroids \\\u003C12 months\n* Pregnant women or likely to be pregnant (without effective contraception) or breastfeeding,\n* Person in urgent situation, person under legal protection measure, or unable to express his \u002F her consent,\n* Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons","ALL","18 Years",{"count":65,"type":66},200,"ESTIMATED","INTERVENTIONAL",[69],"NA","quantification of BTNL molecules in colon cancer in order to determinate if their could be used as a prognostic marquer",[72],"Colonic Cancer","2025-06-13",{"date":75,"type":76},"2025-06-15","ACTUAL",{"date":78,"type":76},"2020-06-30",{"date":80,"type":66},"2028-06",{"name":5,"class":6},1]